Expiration Date: 9/30/08

Goals: To provide the pharmacist with an understanding of the pathological and clinical features of chronic myeloid leukemia and the latest approaches to its treatment. Objectives: After completing this program, the pharmacist will be able to: 1. Describe the general pathological and clinical features of leukemia, including the major types of leukemia. 2. Discuss the epidemiology, pathology, and clinical presentation of chronic myeloid leukemia. 3. Discuss treatment options for chronic myeloid leukemia, including the appropriate use of the drug imatinib mesylate (Gleevec). 4. Describe the role of the pharmacist in the management of patients with chronic myeloid leukemia. According to estimates published in the American Cancer Society’s Cancer Facts & Figures, 1,372,910 Americans will be diagnosed with cancer and 570,280 Americans will die from cancer in 2005, which makes cancer the second most common cause of death behind cardiovascular disease. Although leukemia is not as common as prostate, breast, lung, and colorectal cancer, thi